معرفی
Dr Stephanie Myers is a Senior Lecturer in Medicinal Chemistry at the University of Sunderland, specialising in small-molecule drug discovery and development, particularly in the areas of cancer therapeutics and rare metabolic diseases. She holds an MSc in Drug Chemistry from Newcastle University and a PhD in Medicinal Chemistry from the same institution, completed under the auspices of Cancer Research UK.
Education:
- BSc (Hons) Chemical and Pharmaceutical Sciences – University of Sunderland (2007)
- MSc Drug Chemistry – Newcastle University (Distinction)
- PhD Medicinal Chemistry – Newcastle University (2012)
- Postgraduate Certificate in Academic Practice – University of Wolverhampton/University of Sunderland
Research Interests: Her research focuses on de novo drug design, hit-to-lead and lead-optimisation strategies, synthesis of natural product derivatives, development of kinase and kinesin inhibitors for oncology applications, and prodrug strategies targeting rare genetic disorders such as cystinuria and Wilson's disease.
Scientific Awards & Funding:
- Northern Accelerator Proof-of-Concept Awards (2019, 2020)
- RSC Undergraduate Research Bursary (2021)
- Vice-Chancellor’s Teaching Team Award (2022)
- RSC Robert Boyle Prize for Analytical Science (2022)
- John Dawson Drug Discovery PhD Studentship Award (2023)
- Medical Research Council Impact Accelerator Award (2023)
PhD Supervision: She has supervised or co-supervised five current and former PhD students, including Dr Anna Adam, Noha Elarbi, Alex King, Sean Ranson, and Georgia Howick.
Professional Memberships: Member of the Royal Society of Chemistry (MRSC), Fellow of the Higher Education Academy (FHEA), and Affiliate Member of UKAT.
